IgG1/IgG2 antibody dichotomy in sera of vaccinated or naturally infected dogs with visceral leishmaniosis
- 2 June 2003
- Vol. 21 (19-20) , 2589-2597
- https://doi.org/10.1016/s0264-410x(03)00046-x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Saponins, IL12 and BCG adjuvant in the FML-vaccine formulation against murine visceral leishmaniasisVaccine, 2002
- Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (S o Gon alo do Amarante, RN)Vaccine, 2002
- Impact of canine control on the epidemiology of canine and human visceral leishmaniasis in Brazil.The American Journal of Tropical Medicine and Hygiene, 2001
- Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponinsInternational Immunopharmacology, 2001
- The fucose-mannose ligand-ELISA in the diagnosis and prognosis of canine visceral leishmaniasis in Brazil.The American Journal of Tropical Medicine and Hygiene, 1999
- Vaccination of Swiss Albino mice against experimental visceral leishmaniasis with the FML antigen of LeishmaniadonovaniVaccine, 1999
- Distribution of IgG subclasses in antimonial unresponsive Indian kala-azar patientsClinical and Experimental Immunology, 1998
- The Logic of Visceral Leishmaniasis ControlThe American Journal of Tropical Medicine and Hygiene, 1996
- Control of Zoonotic Visceral Leishmaniasis: Is It Time to Change Strategies?The American Journal of Tropical Medicine and Hygiene, 1995
- The significance of blood levels of IgM, IgA, IgG and IgG subclasses in Sudanese visceral leishmaniasis patientsClinical and Experimental Immunology, 1994